Larvol Delta - Codiak-BioSciences-Announces-FDA-Clearance-of-IND-for-exoASOSTAT6-Patient-Dosing-Expected-1H-2022

exoASO-STAT6 - Codiak

https://www.globenewswire.com/news-release/2021/11/30/2343085/0/en/Codiak-BioSciences-Announces-FDA-Clearance-of-IND-for-exoASO-STAT6-Patient-Dosing-Expected-1H-2022.html

Nov 30, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next